Mesenteric Panniculitis, Sclerosing Mesenteritis and Mesenteric Lipodystrophy: Descriptive Review of a Rare Condition
- PMID: 35966977
- PMCID: PMC9365492
- DOI: 10.1055/s-0042-1743588
Mesenteric Panniculitis, Sclerosing Mesenteritis and Mesenteric Lipodystrophy: Descriptive Review of a Rare Condition
Abstract
Mesenteric panniculitis (MP) is the preferred nomenclature for a continuum of inflammatory diseases of the mesentery. The diagnosis of MP is often based on the appearance of a mass-like structure at the root of the mesentery. Characteristic histology includes focal fat necrosis, chronic inflammation, and sometimes mesenteric fibrosis. At present, robust literature related to diagnosis and management of MP are limited. MP is postulated to be an immune-mediated chronic inflammatory and/or a paraneoplastic disease. A personal or family history of other autoimmune diseases is commonly apparent. Several inciting events have been identified that possibly act as triggers in the development of the disease. Trauma, abdominal surgery, infection, and various cancers have been associated with mesenteric panniculitis. There are several diagnostic and histologic criteria that aid in making the diagnosis of MP. The differential diagnosis for a mesenteric mass includes neoplastic disease, and a biopsy may be indicated to rule out other conditions. While cases of MP with a short duration of symptoms, or spontaneously regression may occur, some patients experience prolonged periods of pain, fever, and alterations in bowel habit, causing significant morbidity. A variety of medical therapies have been suggested for MP. Only two, thalidomide and low-dose naltrexone, have been prospectively evaluated. For patients with chronic MP, good responses to prolonged corticosteroid treatment have been reported. Novel therapies include thalidomide and low-dose naltrexone. Hormonal and immunomodulatory therapies are also used based on small case series, but these treatments may have significant side effects. Surgical intervention is not curative and is avoided except for relief of focal bowel obstruction secondary to fibrotic forms of the disease.
Keywords: adipose tissue; autoimmune disease; computerized tomography; laparoscopy; lymphatics; lymphoma; mesenteric fibrosis; mesenteric lipodystrophy; mesenteric panniculitis; neoplasms; paraneoplastic conditions; positron emission tomography; retractile mesenteritis; sclerosing mesenteritis.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest None declared.
Figures


Similar articles
-
Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity?Am J Surg Pathol. 1997 Apr;21(4):392-8. doi: 10.1097/00000478-199704000-00004. Am J Surg Pathol. 1997. PMID: 9130985
-
Mesenteric Panniculitis (MP): A Frequent Coincidental CT Finding of Debatable Clinical Significance.Rofo. 2018 Nov;190(11):1044-1052. doi: 10.1055/a-0633-3558. Epub 2018 Sep 6. Rofo. 2018. PMID: 30189433 Review. English.
-
Mesenteric panniculitis. Part 1: MDCT--pictorial review.JBR-BTR. 2011 Sep-Oct;94(5):229-40. doi: 10.5334/jbr-btr.658. JBR-BTR. 2011. PMID: 22191287
-
Malignant masquerade sclerosing mesenteritis: A case report and review.Int J Surg Case Rep. 2018;53:265-268. doi: 10.1016/j.ijscr.2018.10.042. Epub 2018 Nov 3. Int J Surg Case Rep. 2018. PMID: 30567051 Free PMC article.
-
Sclerosing mesenteritis: a comprehensive clinical review.Ann Transl Med. 2018 Sep;6(17):336. doi: 10.21037/atm.2018.07.01. Ann Transl Med. 2018. PMID: 30306075 Free PMC article. Review.
Cited by
-
Adverse effects of systemic advanced melanoma therapies-do BRAF/MEK inhibitors increase the incidence of mesenteric panniculitis?Eur Radiol. 2025 May 1. doi: 10.1007/s00330-025-11642-w. Online ahead of print. Eur Radiol. 2025. PMID: 40310541
-
Mesenteric Panniculitis: An Enigma.Iran J Med Sci. 2024 Mar 1;49(3):201-203. doi: 10.30476/IJMS.2023.98397.3074. eCollection 2024 Mar. Iran J Med Sci. 2024. PMID: 38584652 Free PMC article. No abstract available.
-
Mesenteric Panniculitis.Inflamm Intest Dis. 2024 May 22;9(1):157-164. doi: 10.1159/000539432. eCollection 2024 Jan-Dec. Inflamm Intest Dis. 2024. PMID: 39015257 Free PMC article. Review.
-
A clinician's perspective on the new organ mesentery and non-vascular mesenteropathies.Front Physiol. 2024 Sep 4;15:1336908. doi: 10.3389/fphys.2024.1336908. eCollection 2024. Front Physiol. 2024. PMID: 39296517 Free PMC article. Review.
-
Association between mesenteric panniculitis and urolithiasis.Emerg Radiol. 2024 Oct;31(5):661-668. doi: 10.1007/s10140-024-02255-9. Epub 2024 Jul 6. Emerg Radiol. 2024. PMID: 38969913
References
-
- Ehrenpreis E.Mesenteric PanniculitisNORD Rare Disease Database. Published 1988. Updated 2020. Accessed 3/1/2021.https://rarediseases.org/rare-diseases/mesenteric-panniculitis/
-
- Kuhrmeier A. Mesenteriale lipodystrophie. [Mesenteric lipodystrophy] Schweiz Med Wochenschr. 1985;115(36):1218–1224. - PubMed